Late Complications after Bone Marrow Transplantation in Children and Adolescents

Current Problems in Pediatric and Adolescent Health Care

Volumn 28, Issue 9, 1998, Pages 277-297

  Boulad, Farid ^a   Sands, Stephen ^a   Sklar, Charles ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; AGE; BONE MARROW TRANSPLANTATION; CENTRAL NERVOUS SYSTEM DISEASE; CHILD; ENDOCRINE DISEASE; FEMALE; GASTROINTESTINAL DISEASE; HEART DISEASE; HUMAN; INFECTION; KIDNEY DISEASE; LUNG DISEASE; MALE; REVIEW; RISK FACTOR; SECOND CANCER; TIME;

ADOLESCENT; AGE FACTORS; BONE MARROW TRANSPLANTATION; CENTRAL NERVOUS SYSTEM DISEASES; CHILD; ENDOCRINE SYSTEM DISEASES; FEMALE; GASTROINTESTINAL DISEASES; HEART DISEASES; HUMANS; INFECTION; KIDNEY DISEASES; LUNG DISEASES; MALE; NEOPLASMS, SECOND PRIMARY; RISK FACTORS; TIME FACTORS;

EID: 0032185649     PISSN: 15385442     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0045-9380(98)80030-3     Document Type: Article

References (196)

1. Gatti RA, Meuwissen HJ, Allen HD, Hong R, Good RA. Immunological reconstitution of sex-linked lymphopenicimmunological deficiency. Lancet 1968;2:1366-9.
2. Bach FH, Albertini RJ, Joo P, Anderson JL, Bortin MM. Bone-marrow transplantation in a patient with the Wiskott-Aldrich syndrome. Lancet 1968;2:1364-6.
3. Gorin NC, Gale RP, Armitage JO. Autologous bone marrow transplants: different indications in Europe and North America. Lancet 1989;2:312-8.
4. Kernan NA, Bartsch G, Ash RC, Beatty PG, Champlin R, Filipovich A, et al. Analysis of 462 transplantations from unrelated donors facilitated by the National Marrow Donor Program. N Engl J Med 1993;328:593-602.
5. Eaves C. Peripheral blood stem cells reach new heights. Blood 1993;82:1957-9.
6. Kurtzberg J, Laughlin M, Graham ML, Smith C, Olson JF, Halperin EC, et al. Placental blood as a source of hematopoietic stem cells for transplantation into unrelated recipients. N Engl J Med 1996;335:157-66.
7. Aversa F, Tabilio A, Terenzi A, Velardi A, Falzetti F, Giannoni C, et al. Successful engraftment of T-cell-depleted haploidentical three-loci incompatible transplants in leukemia by addition of recombinant human granulocyte colony-stimulating factor-mobilized peripheral blood progenitor cells to bone marrow inoculum. Blood 1994;84:3948-55.
8. Brochstein JA, Kernan NA, Groshen S, Cirrincione C, Shank B, Emanuel D, et al. Allogeneic bone marrow transplantation after hyperfractionated total-body irradiation and cyclophosphamide in children with acute leukemia. N Engl J Med 1987;317:1618-24.
9. Gillio AP, Boulad F, Small TN, Kernan NA, Reyes B, Childs BH, et al. Comparison of long-term outcome of children with severe aplastic anemia treated with immunosuppression versus bone marrow transplantation. Biol Blood Marrow Transplant 1997;3:18-24.
10. Lucarelli G, Giardini C, Baronciani D. Bone marrow transplantation in thalassemia. Semin Hematol 1995;32:297-303.
11. Horowitz ME, Kinsella TJ, Kinsella LH. Total-body irradiation and autologous bone marrow transplant in the treatment of high-risk Ewing's sarcoma and rhabdomyosarcoma. J Clin Oncol 1993;11:1911-8.
12. O'Reilly RJ, Papadopoulos E, Boulad F. Allogeneic bone marrow transplantation. In: Bach FH, Auchincloss H, editors. Transplantation immunology. New York: Wiley-Liss; 1995. p. 161-98.
13. O'Reilly RJ, Friedrich W, Small TN. Transplantation approaches for severe combined immunodeficiency, Wiskott-Aldrich syndrome, and other lethal genetic combined immunodeficiency disorders. In: Forman SJ, Blume KG, Thomas ED, editors. Bone marrow transplantation. Cambridge: Blackwell Scientific; 1994. p. 849-73.
14. Yahalom J, Fuks ZY. Strategies for the use of total body irradiation as systemic therapy in leukemia and lymphoma. In: Armitage JO, Antman KH, editors. High dose cancer therapy. Baltimore: Williams and Wilkins; 1992. p. 61-83.
15. Shank B, Chu FCH, Dinsmore R, Kapoor N, Kirkpatrick D, Teitelbaum H, et al. Hyperfractionated total body irradiation for bone marrow transplantation: results in seventy leukemia patients with allogeneic transplants. Int J Radiat Oncol Biol Phys 1983;9:1607-11.
16. Keating A. Autologous bone marrow transplantation. In: Armitage JO, Antman KH, editors. High dose cancer therapy. Baltimore: Williams and Wilkins, 1992. p. 162-81.
17. Atkinson K. Chronic graft-versus-host disease. Bone Marrow Transplant 1990;5:69-82.
18. Sullivan KM, Agura E, Anasetti C, Appelbaum F, Badger C, Bearman S, et al. Chronic graft-versus-host disease and other late complications of bone marrow transplantation. Semin Hematol 1991;28:250-9.
19. Sierra J, Storer B, Hansen JA, Bjerke JW, Martin PJ, Petersdorf EW, et al. Transplantation of marrow cells from unrelated donors for treatment of high risk acute leukemia: the effect of tumor burden, donor HLA-matching and marrow cell dose. Blood 1997;89:4226-35.
20. Sullivan KM, Shulman HM, Storb R, Weiden PL, Witherspoon RP, McDonald GB, et al. Chronic graft-versus-host disease in 52 patients: adverse natural course and successful treatment with combination immunosuppression. Blood 1981;57:267-76.
21. Sullivan KM, Witherspoon RP, Storb R, Weiden P, Flournoy N, Dahlberg S, et al. Prednisone and azathioprine compared with prednisone and placebo for treatment of chronic graft-versus-host disease: prognostic influence of prolonged thrombocytopenia after allogeneic marrow transplantation. Blood 1988;72:546-54.
22. Sullivan KM, Witherspoon RP, Storb R, Deeg HJ, Dahlberg S, Sanders JE, et al. Alternating day cyclosporine and prednisone for treatment of high risk chronic graft-versus-host disease. Blood 1988;72:555-61.
23. Vogelsang GB, Farmer ER, Hess AD, Altamonte V, Beschomer WE, Jabs DA, et al. Thalidomide for the treatment of chronic graft-versus-host disease. N Engl J Med 1992;326:1055-8.
24. Lee SJ, Wegner SA, McGarigle CJ, Bierer BE, Antin JH. Treatment of chronic graft-versus-host disease with clofazimine. Blood 1997;89:2298-302.
25. Aubin F, Brion A, Deconinck E, Plouvier E, Herve P, Humbert P, et al. Phototherapy in the treatment of cutaneous graft-versus-host disease: preliminary experience in resistant patients. Transplantation 1995;59:151-5.
26. Vogelsang GB, Wolff D, Altomonte V, Farmer E, Morison WL, Corio R, et al. Treatment of chronic graft-versus-host disease with ultraviolet irradiation and psoralen (PUVA). Bone Marrow Transplant 1996;17:1061-7.
27. Sklar C. Growth and endocrine disturbances after bone marrow transplantation in childhood. Acta Paediatr 1995;411:57-61.
28. Sanders JE, the Seattle Marrow Transplant Team. The impact of marrow transplant preparative regimens on subsequent growth and development. Semin Hematol 1991;28:244-9.
29. Giorgiani G, Bozzola M, Locatelli F, Picco P, Zecca M, Cisternino M, et al. Role of busulfan and total body irradiation on growth of prepubertal children receiving bone marrow transplantation and results of treatment with recombinant human growth hormone. Blood 1995;86:825-31.
30. Adan L, de Lanversin M-L, Thalassinos C, Souberbielle JC, Fischer A, Brauner R. Growth after bone marrow transplantation in young children conditioned with chemotherapy alone. Bone Marrow Transplant 1997;19:253-6.
31. Shankar SM, Bunnin NJ, Moshang T Jr. Growth in children undergoing bone marrow transplantation after busulfan and cyclophosphamide conditioning. J Pediatr Hematol Oncol 1996;18:362-6.
32. Clement-De Boers A, Oostdijk W, Van Weel-Sipman MH, Van den Broeck J, Wit JM, Vossen JM. Final height and hormonal function after bone marrow transplantation in children. J Pediatr 1996;129:544-50.
33. Michel G, Socié G, Gebhard F, Bernaudin F, Thuret I, Vannier JP, et al. Late effects of allogeneic bone marrow transplantation for children with acute myeloblastic leukemia in first complete remission: the impact of conditioning regimen without total-body irradiation - a report from the Société Française de Greffe de Moelle. J Clin Oncol 1997;15:2238-46.
34. Bushhouse S, Ramsay NKC, Pescovitz OH, Kim T, Robison LL. Growth in children following irradiation for bone marrow transplantation. Am J Pediatr 1989;11(2):134-40.
35. Holm K, Nysom K, Rasmussen MH, Hertz H, Jacobsen N, Skakkebæk NE, et al. Growth, growth hormone and final height after BMT: possible recovery of irradiation-induced growth hormone insufficiency. Bone Marrow Transplant 1996;18:163-70.
36. Sanders JE, Pritchard S, Mahoney P, Amos D, Buckner CD, Witherspoon RP, et al. Growth and development following marrow transplantation for leukemia. Blood 1986;68:1129-35.
37. Sanders JE. Endocrine problems in children after bone marrow transplant for hematological malignancies. Bone Marrow Transplant 1991;8:2-4.
38. Mulhern R, Kovnar EH, Langstan J, Carter M, Fairclough D, Leigh L, et al. Long-term survivors of leukemia treated in infancy: factors associated with neuropsychological status. J Clin Oncol 1992;10:1095-102.
39. Brauner R, Fontoura M, Zucker JM, Devergie A, Souberbielle JC, Prevot-Saucet C, et al. Growth and growth hormone secretion after bone marrow transplantation. Arch Dis Child 1993;68:458-63.
40. Thomas BC, Stanhope R, Plowman PN, Leiper AD. Growth following single fraction and fractionated total body irradiation for bone marrow transplantation. Eur J Pediatr 1993;152:888-92.
41. Withers HR. Biologic basis for altered fractionation schemes. Cancer 1985;55:2086-95.
42. Brauner R, Adan L, Souberbielle JC, Esperou H, Michon J, Devergie A, et al. Contribution of growth hormone deficiency to the growth failure that follows bone marrow transplantation. J Pediatr 1997;130:785-92.
43. Wingard JR, Plotnick LP, Freemer CS, Zahurak M, Piantadosi S, Miller DF, et al. Growth in children after bone marrow transplantation: busulfan plus cyclophosphamide versus cyclophosphamide plus total body irradiation. Blood 1992;79:1068-73.
44. Bozzola M, Giorgiani G, Locatelli F, Cisternino M, Gambarana D, Zecca M, et al. Growth in children after bone marrow transplantation. Horm Res 1993;39:122-6.
45. Huma Z, Boulad F, Black P, Heller G, Sklar C. Growth in children after bone marrow transplantation for acute leukemia. Blood 1995;86:819-24.
46. Willi SM, Cooke K, Goldwein J, August CS, Olshan JS, Moshang T Jr. Growth in children after bone marrow transplantation for advanced neuroblastoma compared with growth after transplantation for leukemia or aplastic anemia. J Pediatr 1992;120:726-32.
47. Sklar C, Sarafoglou K, Whittam E. Efficacy of insulin-like growth factor binding protein 3 in predicting the growth hormone response to provocative testing in children treated with cranial irradiation. Acta Endocrinol (Copenh) 1993;129:511-5.
48. Fletcher JM, Copeland DR. Neurobehavioral effects of central nervous system prophylactic treatment of cancer in children. J Clin Exp Neuropsychol 1988;10:495-538.
49. Papadimitrou A, Uruena M, Stanhope R, Leiper AD. Growth hormone treatment of growth failure secondary to total body irradiation and bone marrow transplantation. Arch Dis Child 1991;66:689-92.
50. Ogilvy-Stuart AL, Clark DJ, Wallace WHB, Gibson BE, Stevens RF, Shalet SM, et al. Endocrine deficit after fractionated total body irradiation. Arch Dis Child 1992;67:1107-10.
51. Thomas BC, Stanhope R, Plowman PN, Leiper AD. Endocrine function following single fraction and fractionated total body irradiation for bone marrow transplantation in childhood. Acta Endocrinologica 1993;128:508-12.
52. Sarafoglou K, Boulad F, Gillio A, Sklar C. Gonadal function after bone marrow transplantation for acute leukemia during childhood. J Pediatr 1997;130:210-6.
53. Sklar CA, Kim TH, Ramsay NKC. Thyroid dysfunction among long-term survivors of bone marrow transplantation. Am J Med 1982; 73:688-94.
54. Katsanis E, Shapiro RS, Robison LL, Haake RJ, Kim T, Pescovitz OH, et al. Thyroid dysfunction following bone marrow transplantation: long-term follow-up of 80 pediatric patients. Bone Marrow Transplant 1990;5:335-40.
55. Boulad F, Bromley M, Black P, Heller G, Sarafoglou K, Gillio A, et al. Thyroid dysfunction following bone marrow transplantation using hyperfractionated radiation. Bone Marrow Transplant 1995;15:71-6.
56. Holland FJ, McConnon JK, Volpé R, Saunders EF. Concordant Graves' disease after bone marrow transplantation: implications for pathogenesis. J Clin Endocrinol Metab 1991;72:837-40.
57. Wyatt DT, Lum LG, Casper J, Hunter J, Camitta B. Autoimmune thyroiditis after bone marrow transplantation. Bone Marrow Transplant 1990;5:357-61.
58. Tucker MA, Jones PH, Boice JD, Robison LL, Stone BJ, Stovall M, et al. Therapeutic radiation at a young age is linked to secondary thyroid cancer. Cancer Res 1991;51:2885-8.
59. Sarafoglou K, La Quaglia M, Lindsley K, Wollner N, Tan C, Sklar C. Thyroid neoplasms following therapeutic radiation during childhood [abstract]. Presented at the 75th Annual Meeting of the Endocrine Society; Las Vegas, Nev, June 9-12, 1993.
60. Uderzo C, Fraschini D, Balduzzi A, Galimberti S, Arrigo C, Biagi E, et al. Long-term effects of bone marrow transplantation on dental status in children with leukemia. Bone Marrow Transplant 1997;20:865-9.
61. Sanders JE, Hawley J, Levy W, Gooley T, Buckner CD, Deeg J, et al. Pregnancies following high-dose cyclophosphamide with or without high-dose busulfan or total-body irradiation and bone marrow transplantation. Blood 1996;87:3045-52.
62. Sklar CA, Robison LL, Nesbit ME, Sather HN, Meadows AT, Ortega JA, et al. Effects of radiation on testicular function in long-term survivors of childhood acute lymphoblastic leukemia: a report from the Childrens Cancer Study Group. J Clin Oncol 1990;8:1981-7.
63. Sklar CA, Kim TH, Ramsay NKC. Testicular function following bone marrow transplantation performed during or after puberty. Cancer 1984;53:1498-501.
64. Sanders JE, Buckner CD, Amos D, Levy W, Applebaum FR, Doney K, et al. Ovarian function following marrow transplantation for aplastic anemia or leukemia. J Clin Oncol 1988;6:813-8.
65. Byrne J, Fears TR, Gail MH, Pee D, Connelly RR, Austin DF, et al. Early menopause in long-term survivors of cancer during adolescence. Am J Obstet Gynecol 1992;166:788-93.
66. De Sanctis V, Galimberti M, Lucarelli G, Polchi P, Vullo C. Gonadal function after allogenic bone marrow transplantation for thalassaemia. Arch Dis Child 1991;66:517-20.
67. Sklar CA, Kim TH, Williamson JF, Ramsay NKC. Ovarian function after successful bone marrow transplantation in post-menarcheal females. Med Pediatr Oncol 1983;11:361-4.
68. Lorini R, Cortona L, Scaramuzza A, De Stefano P, Locatelli F, Bonetti F, et al. Hyperinsulinemia in children and adolescents after bone marrow transplantation. Bone Marrow Transplant 1995;15:873-7.
69. Socié G, Cahn JY, Carmelo J, Vernant JP, Jouet JP, Ifrah N, et al. Avascular necrosis of bone after allogeneic bone marrow transplantation: analysis of risk factors for 4388 patients by the Société de Greffe de Moelle (SFGM). Br J Haemat 1997;97:865-70.
70. Mascarin M, Giavitto M, Zanazzo GA, Andolina M, Cova M, Accorsi E, et al. Avascular necrosis of bone in children undergoing allogeneic bone marrow transplantation. Cancer 1991;68:655-9.
71. Enright H, Haake R, Weisdorf D. Avascular necrosis of bone: a common serious complication of allogeneic bone marrow transplantation. Am J Med 1990;89:733-8.
72. Aisenberg J, Hsiah K, Kalaitzoglou G, Whittam E, Heller G, Schneider R, et al. Bone mineral density (BMD) in long-term survivors of childhood cancer. J Pediatr Hematol Oncol 1998;20:241-5.
73. Stern JM, Chestnut CH, Bruemmer B, Sullivan KM, Lenssen PS, Aker SN, et al. Bone density loss during treatment of chronic GVHD. Bone Marrow Transplant 1996;17:395-400.
74. Gilsanz V, Carlson ME, Roe TF, Ortega JA. Osteoporosis after cranial irradiation for acute lymphoblastic leukemia. J Pediatr 1990;117:238-44.
75. Nussey SS, Hyer SL, Brada M, Leiper AD. Bone mineralization after treatment of growth hormone deficiency in survivors of childhood malignancy. Acta Paediatr Suppl 1994;399:9-14.
76. Parkman R, Weinberg KI. Immunological reconstitution following bone marrow transplantation. Immunol Rev 1997;157:73-8.
77. Atkinson K, Luckhurst E, Penny R, Warren H, Biggs J. Immunologic reconstitution after allogeneic marrow transplantation in man. Transplant Proc 1983;15:474-9.
78. Lum L. The kinetics of immune reconstitution after human marrow transplantation. Blood 1987;69:369-80.
79. Atkinson K. Reconstruction of the haemopoietic and immune systems after marrow transplantation. Bone Marrow Transplant 1990;5:209-26.
80. Foot ABM, Potter MN, Donaldson C, Cornish JM, Wallington TB, Oakhill A, et al. Immune reconstitution after BMT in children. Bone Marrow Transplant 1993;11:7-13.
81. Small TNS, Keever CA, Winer-Fedus S, Heller G, O'Reilly RJ, Flomenberg N. B-cell differentiation following autologous, conventional, or T-cell depleted bone marrow transplantation: a recapitulation of normal B-cell ontogeny. Blood 1990;76:1647-56.
82. Storek J, Saxon A. Reconstitution of B-cell immunity following bone marrow transplantation. Bone Marrow Transplant 1992;9:395-408.
83. Small TNS, Avigan D, Dupont B, Smith K, Black P, Heller G, et al. Immune reconstitution following T-cell depleted bone marrow transplantation: effect of age and posttransplant graft rejection prophylaxis. Biol Blood Marrow Transplant 1997;3:65-75.
84. Keever CA, Small TN, Flomenberg N, Heller G, Pekle K, Black P, et al. Immune reconstitution following bone marrow transplantation: comparison of recipients of T-cell depleted marrow with recipients of conventional marrow grafts. Blood 1989;73:1340-50.
85. Talmadge JE, Reed E, Ino K, Kessinger A, Kuszynski C, Heimann D, et al. Rapid immunologic reconstitution following transplantation of mobilized peripheral blood stem cells as compared to bone marrow. Bone Marrow Transplant 1997;19:161-72.
86. Chan CY, Molrine DC, Antin JH, Wheeler C, Guinan EC, Weinstein HJ, et al. Antibody responses to tetanus toxoid and haemophilus influenzae type b conjugate vaccines following autologous peripheral blood stem cell transplantation (PBSCT). Bone Marrow Transplant 1997;20:33-8.
87. Atkinson K, Storb R, Prentice RL, Weiden PL, Witherspoon RP, Sullivan K, et al. Analysis of late infections in 89 long-term survivors of bone marrow transplantation. Blood 1979;53:720-31.
88. Atkinson K, Farewell V, Storb R, Tsoi MS, Sullivan KM, Witherspoon RP, et al. Analysis of late infections after human bone marrow transplantation: role of genotypic nonidentity between marrow donor and recipient and of nonspecific suppressor cells in patients with chronic graft-versus-host disease. Blood 1982;60:714-20.
89. Hoyle C, Goldman JM. Life-threatening infections occurring more than 3 months after BMT. Bone Marrow Transplant 1994;14:247-52.
90. Roy V, Ochs L, Weisdorf D. Late infections following allogeneic bone marrow transplantation: suggested strategies for prophylaxis. Leuk Lymphoma 1997;26:1-15.
91. Ochs L, Shu XO, Miller J, Enright H, Wagner J, Filipovich A, et al. Late infections after allogeneic bone marrow transplantation: comparison of incidence in related and unrelated donor transplant recipients. Blood 1995;86:3979-86.
92. Storek J, Gooley T, Witherspoon RP, Sullivan KM, Storb R. Infectious morbidity in long term survivors of allogeneic marrow transplantation is associated with low CD4 T-cell counts. Am J Hematol 1997;54:131-8.
93. Winston DJ, Schiffman G, Wang DC, Feig SA, Lin CH, Marso EL, et al. Pneumococcal infections after human bone marrow transplantation. Ann Intern Med 1979;91:835-41.
94. Rege K, Mehta J, Treleaven J, Jameson B, Meller ST, Mitchell P, et al. Fatal pneumococcal infections following allogeneic bone marrow transplant. Bone Marrow Transplant 1994;14:903-6.
95. Ambrosino D. Impaired polysaccharide responses in immunodeficient patients: relevance to bone marrow transplant patients. Bone Marrow Transplant 1991;7:48-51.
96. Sheridan JF, Tutschka PJ, Sedmak DD, Copelan EA. Immunoglobulin G subclass deficiency and pneumococcal infection after allogeneic bone marrow transplantation. Blood 1990;75:1583-6.
97. Fielding AK. Prophylaxis against late infection following splenectomy and bone marrow transplant. Blood Reviews 1994;8:179-91.
98. Locksley RM, Flournoy N, Sullivan KM, Meyers JD. Infection with Varicella-Zoster after marrow transplantation. J Infect Dis 1985;152:1172-81.
99. Masaoka T, Hiraoka A, Teshima H, Tominaga N. Varicella-zoster virus infection in immunocompromised patients. J Med Virol 1993;(suppl 1):82-4.
100. Wacker P, Hartmann O, Benhamou E, Salloum E, Lemerle J. Varicella-zoster virus infection after autologous bone marrow transplantation in children. Bone Marrow Transplant 1989;4:191-4.
101. Kawasaki H, Takayama J, Ohira M. Herpes zoster infection after bone marrow transplantation in children. J Pediatr 1996;128:353-6.
102. Witherspoon RP, Storb R, Ochs HD, Flournoy N, Kopecky KJ, Sullivan KM, et al. Recovery of antibody production in human allogeneic marrow graft recipients: influence of time posttransplantation, the presence or absence of chronic graft-versus-host disease, and antithymocyte globulin treatment. Blood 1981;58:360-8.
103. Molrine DC, Guinan EC, Antin JH, Parsons SK, Weinstein HJ, Wheeler C, et al. Donor immunization with Haemophilus influenzae type B (HIB)-conjugate vaccine in allogeneic bone marrow transplantation. Blood 1996;87:3012-8.
104. Belkacemi Y, Ozsahin M, Pene F, Rio B, Laporte JP, Leblond V, et al. Cataractogenesis after total body irradiation. Int J Radiat Oncol Biol Phys 1996;35:53-60.
105. Calissendorff BM, Bolme P, el Azazi M. The development of cataract in children as a late side-effect of bone marrow transplantation. Bone Marrow Transplant 1991;7:427-9.
106. Deeg HJ, Flournoy N, Sullivan KM, Sheehan K, Buckner CD, Sanders JE, et al. Cataract after total body irradiation and marrow transplantation: a sparing effect of dose fractionation. Int J Radiat Oncol Biol Phys 1984;10:957-64.
107. Dahllöf G, Krekmanova L, Kopp S, Borgström B, Forsberg CM, Ringden O. Craniomandibular dysfunction in children treated with total-body irradiation and bone marrow transplantation. Acta Odontologica Scand 1994;52:99-105.
108. Ljungman P, Wiklund-Hammarsten M, Duraj V, Hammarstrom L, Lonnqvist B, Paulin T, et al. Response to tetanus toxoid immunization after allogeneic bone marrow transplantation. J Infect Dis 1990;162:496-500.
109. Parkkali T, Olander RM, Ruutu T, Vuontela K, Volin L, Eskola J, et al. A randomized comparison between early and late vaccination with tetanus toxoid vaccine after allogeneic BMT. Bone Marrow Transplant 1997;19:933-8.
110. Li Volti S, Mauro L, Di Gregorio F, Romeo MA, Lupo L, Pizzarelli G, et al. Immune status and immune response to diphtheria-tetanus and polio vaccines in allogeneic marrow-transplanted thalassemic patients. Bone Marrow Transplant 1994;14:225-7.
111. Ljungman P, Duraj V, Magnius L. Response to immunization against polio after allogeneic marrow transplantation. Bone Marrow Transplant 1991;7:89-93.
112. Pauksen K, Hammarstrom L, Ljungman P, Sjolin J, Oberg G, Lonnerholm G, et al. Immunity to poliovirus and immunization with inactivated poliovirus vaccine after autologous bone marrow transplantation. Clin Infect Dis 1994;18:547-52.
113. Engelhard D, Handsher R, Naparstek E, Hardan I, Strauss N, Aker M, et al. Immune response to polio vaccination in bone marrow transplant recipients. Bone Marrow Transplant 1991;8:295-300.
114. Parkkali T, Kayhty H, Ruutu T, Volin L, Eskola J, Ruutu P. A comparison of early and late vaccination with Haemophilus influenzae type b conjugate and pneumococcal polysaccharide vaccines after allogeneic BMT. Bone Marrow Transplant 1996;18:961-7.
115. Guinan EC, Molrine DC, Antin JH, Lee MC, Weinstein HJ, Sallan SE, et al. Polysaccharide conjugate vaccine responses in bone marrow transplant patients. Transplantation 1994;57:677-84.
116. Winston DJ, Schiffman G, Champlin RE, Feig SA, Gale RP. Pneumococcal vaccination of recipients of bone marrow transplants. Arch Intern Med 1983;143:1735-7.
117. Giebink GS, Warkentin PI, Ramsay NK, Kersey JH. Titers of antibody to pneumococci in allogeneic bone marrow transplant recipients before and after vaccination with pneumococcal vaccine. J Infect Dis 1986;154:590-6.
118. Ljungman P, Fridell E, Lonnqvist B, Bolme P, Bottiger M, Gahrton G, et al. Efficacy and safety of vaccination of marrow transplant recipients with a live attenuated measles, mumps, and rubella vaccine. J Infect Dis 1989;159:610-5.
119. Ljungman P, Lewensohn-Fuchs I, Hammarstrom L, Aschan J, Brandt L, Bolme P, et al. Long-term immunity to measles, mumps, and Rubella after allogeneic bone marrow transplantation. Blood 1998;84:657-63.
120. Sauerbrei A, Prager J, Hengst U, Zintl F, Wutzler P. Varicella vaccination in children after bone marrow transplantation. Bone Marrow Transplant 1997;20:381-3.
121. Li Volti S, Di Gregorio F, Romeo MA, Cannella A, Pizzarelli G, Sciacca A, et al. Immune status and the immune response to hepatitis B virus vaccine in thalassemic patients after allogeneic bone marrow transplantation. Bone Marrow Transplant 1997;19:157-60.
122. Engelhard D, Nagler A, Hardan I, Morag A, Aker M, Baciu H, et al. Antibody response to a two-dose regimen of influenza vaccine in allogeneic T-cell depleted and autologous BMT recipients. Bone Marrow Transplant 1993;11:1-5.
123. Sanders J. Bone marrow transplantation for pediatric malignancies. Pediatr Clin North Am 1997;44:1005-20.
124. Davidson A, Childs J, Hopewell JW, Tait D. Functional neurological outcome in leukaemic children receiving repeated cranial irradiation. Radiother Oncol 1994;31:101-9.
125. Stehbens JA, Kaleita TA, Noll RB, et al. CNS prophylaxis of childhood leukemia: what are the long term neurological, neuropsychological and behavioral effects. Neuropsychol Rev 1991;2:147-77.
126. Moore IM, Kramer JH, Wara W, Kalberg F, Ablin AR. Cognitive functioning in children with leukemia: effect of radiation dose and time since irradiation. Cancer 1991;68:1913-7.
127. Brouwers P. Neuropsychological abilities of long-term survivors of childhood leukemia. In: Aaronson NK, Beckman J, editors. The quality of life of cancer patients. New York: Raven Press, 1987. p. 154-65.
128. Packer R, Meadows AT, Rourke LB, et al. Long-term sequelae of cancer treatment on the central nervous system in childhood. Med Pediatr Oncol 1987;15:241-53.
129. Wiznitzer M, Packer R, August CS, Burkey E. Neurological complications of bone marrow transplantation in children. Ann Neurol 1984;16:569-76.
130. McGuire T, Sanders J, Hill D, Buckner CD, Sullivan K. Neuropsychological function in children given total body irradiation for marrow transplantation. Exp Hematol 1991;19:578.
131. Sanders J, Flowers M, Siadek M, McGuire T. Negative impact of prior central nervous system irradiation on growth and neuropsychological function after total body irradiation and bone marrow transplant. Blood 1994;84:985.
132. Smedler A, Ringden K, Bergman H, Bolme P. Sensory-motor and cognitive functioning in children who have undergone bone marrow transplantation. Acta Paediatr 1990;79:613-21.
133. Smedler A, Bolme P. Neuropsychological deficits in very young bone marrow transplant recipients. Acta Paediatr 1998;84:429-33.
134. Smedler A, Nissen C, Bolme P. Total body irradiation: a neuropsychological risk factor in pediatric bone marrow transplant recipients. Acta Paediatr 1995;84:325-30.
135. Kramer H, Crittenden M, DeSantes K, Cowan MJ. Cognitive and adaptive behavior 1 and 3 years following bone marrow transplantation. Bone Marrow Transplant 1997;19:607-13.
136. Cool V. Long-term neuropsychological risks in pediatric bone marrow transplant: what do we know? Bone Marrow Transplant 1996;18(suppl):45-9.
137. Wheeler K, Leiper A, Jannoun L, Chessells J. Medical cost of curing childhood acute lymphoblastic leukemia. BMJ 1988;296:162-6.
138. Copeland D. Neuropsychological and psychosocial effects of childhood leukemia and its treatment. CA Cancer J Clin 1992;42:283-95.
139. Thuret I, Michel G, Carla H, Chambost H, Blasie D, Demeocq F, et al. Long-term side effects in children receiving allogeneic bone marrow transplantation in first complete remission of acute leukaemia. Bone Marrow Transplant 1995;15:337-41.
140. Phipps S, Brenner M, Heslop H, Krance R, Jayawardene D, Mulhern R. Psychological effects of bone marrow transplantation on children and adolescents: preliminary report of a longitudinal study. Bone Marrow Transplant 1995;15:829-35.
141. Parth P, Kennedy RS, Lane NE, Dunlap WP, Ordy JM. Motor and cognitive testing of bone marrow transplant patients after chemoradiotherapy. Percept Mot Skills 1989;68:1227-41.
142. Kramer JH, Crittenden M, Halberg F, Wara D, Cowan M. A prospective study of cognitive functioning following low-dose cranial radiation for bone marrow transplantation. Pediatrics 1992;90:447-50.
143. Pot-Mees CL. The psychological effects of bone marrow transplantation in children. Eburon, Netherlands: Delft, 1989.
144. Chou R, Wongramer J, Wara D, Matthay K, Crittenden M, Swift P, et al. Toxicities of total-body irradiation for pediatric bone marrow transplantation. Int J Oncol Biol Phys 1996;34:843-51.
145. Kaleita TA, Shields D, Tesler A, Feig S. Normal neurodevelopment in four young children treated with bone marrow transplantation for acute leukemia or aplastic anemia. Pediatrics 1989;83:753-7.
146. Thompson CB, Sanders JE, Flournoy N, Buckner D, Thomas ED. The risks of central nervous system relapse and leukoencephalopathy in patients receiving marrow transplants for acute leukemia. Blood 1986;67:195-9.
147. Sureda A, Perez de Oteyza J, Garcia Larana J, Odriozola J. High-dose busulfan and seizures. Ann Intern Med 1989;111:543-4.
148. Wolff SN, Herzig RH, Fay JW, LeMaistre CF, Frei-Lahr D, Lowder J, et al. High-dose thiotepa with autologous bone marrow transplantation for metastatic malignant melanoma: results of phase I and II studies of the North American Bone Marrow Transplantation Group. J Clin Oncol 1989;7:245-9.
149. Reece DE, Frei-Lahr DA, Shepherd JD, Dorovini-Zis K, Gascoyne RD, Graaeb DA, et al. Neurologic complications in allogeneic bone marrow transplant patients receiving cyclosporin. Bone Marrow Transplant 1991;8:393-401.
150. Patchell RA, White CL, Clark AW, Beschorner WE, Santos GW. Neurologic complications of bone marrow transplantation. Neurology 1985;35:300-6.
151. Gallardo D, Ferra C, Berlanga JJ, de la Banda E, Ponce C, Salar A, et al. Neurologic complications after allogeneic bone marrow transplantation. Bone Marrow Transplant 1996;18:1135-9.
152. Bogdanovic G, Grandien M, Brytting M, Fridell E. BK and JC viruses - 2 polyomaviruses causing disease in immunosuppressed patients. Lakartidningen 1992;89:3925-6.
153. Cole PD, Stiles J, Boulad F, Small TN, O'Reilly RJ, George D, et al. Successful treatment of human herpes virus 6 encephalitis in a bone marrow transplantation recipient. Clin Infect Dis. In press.
154. Openshaw H. Peripheral neuropathy after bone marrow transplantation. Biol Blood Marrow Transplant 1997;3:202-9.
155. Perry A, Mehta J, Iveson T, Treleaven J, Powles R. Guillain-Barre syndrome after bone marrow transplantation. Bone Marrow Transplant 1994;14:165-7.
156. Parker PM, Openshaw H, Forman SJ. Myositis associated with graft-versus-host disease. Curr Opin Rheumatol 1997;9:513-9.
157. O'Connell TX, Berenbaum MC. Cardiac and pulmonary effects of high-dose cyclophosphamide and isophosphamide. Cancer Res 1974;34:1586-91.
158. Steinherz LJ, Steinherz PG, Tan CTC, Heller G, Murphy ML. Cardiac toxicity 4-20 years after completing anthracycline therapy. JAMA 1991;266:250-7.
159. Arsenian MA. Cardiovascular sequelae of therapeutic thoracic radiation. Proc Cardiovasc Dis 1991;33:299-312.
160. Larsen RL, Barber G, Heise CT, August CS. Exercise assessment of cardiac function in children and young adults before and after bone marrow transplantation. Pediatrics 1992;89:722-9.
161. Pihkala J, Saarinen UM, Lundstrom U, Salmo M, Virkola K, Virtanen K, et al. Effects of bone marrow transplantation on myocardial function in children. Bone Marrow Transplant 1994;13:149-55.
162. Rovelli A, Pezzini C, Silvestri D, Tana F, Galli MA, Uderzo C. Cardiac and respiratory function after bone marrow transplantation in children with leukemia. Bone Marrow Transplant 1995;16:571-6.
163. Gore EM, Lawton CA, Ash RC, Lipchik RJ. Pulmonary function changes in long term survivors of bone marrow transplantation. Int J Radiat Oncol Biol Phys 1996;36:67-75.
164. Nysom K, Holm K, Hesse B, Ulrik CS, Jacobsen N, Bisgaard H, et al. Lung function after allogeneic bone marrow transplantation for leukaemia or lymphoma. Arch Dis Child 1996;74:432-6.
165. Quigley PM, Yeager AM, Loughlin GM. The effects of bone marrow transplantation on pulmonary function in children. Pediatr Pulmonol 1994;18:361-7.
166. Arvidson J, Bratteby LE, Carlson K, Hagberg H, Kreuger A, Simonsson B, et al. Pulmonary function after autologous bone marrow transplantation in children. Bone Marrow Transplant 1994;14:117-23.
167. Ghalie R, Szidon JP, Thompson L, Nawas YN, Dolce A, Kaizer H. Evaluation of pulmonary complications after bone marrow transplantation: the role of pretransplant pulmonary function tests. Bone Marrow Transplant 1992;10:359-65.
168. Nenadov-Beck M, Meresse V, Hartman O, Gaultier C. Long-term pulmonary sequelae after autologous bone marrow transplantation in children without total body irradiation. Bone Marrow Transplant 1995;16:771-5.
169. Beschorner WE, Saral R, Hutchins GM, Tutschka PJ, Santos GW. Lymphocytic bronchitis associated with graft-versus-host disease in recipients of bone marrow transplants. N Engl J Med 1978;299:1030-6.
170. Schultz KR, Green GJ, Wensley D, Sargent MA, Magee JF, Spinelli JJ, et al. Obstructive lung disease in children after allogeneic bone marrow transplantation. Blood 1994;84:3212-20.
171. Clark JG, Crawford SW, Madtes DK, Sullivan KM. Obstructive lung disease after allogeneic marrow transplantation: clinical presentation and course. Ann Intern Med 1989;111:368-76.
172. Springmeyer SC, Flournoy N, Sullivan KM, Storb R, Thomas ED. Pulmonary function changes in long term survivors of allogeneic marrow transplantation. In: Gale RP, editor. Recent advances in bone marrow transplantation. New York: Alan Liss, 1983. p. 343-53.
173. Sargent MA, Cairns RA, Murdoch MJ, Nadel HR, Wensley D, Schultz KR. Obstructive lung disease in children after allogeneic bone marrow transplantation: evaluation with high resolution CT. AJR Am J Roentgenol 1995;164:693-6.
174. Kaplan EB, Wodell RA, Wilmott RW, Leifer B, Lesser ML, August CS. Late effects of bone marrow transplantation on pulmonary function in children. Bone Marrow Transplant 1994;14:613-21.
175. Lopes-Cardozo B, Zoetelief H, van Bekkum DW, Zurcher C, Hagenbeek A. Lung damage following bone marrow transplantation: I. The contribution of irradiation. Int J Radiat Oncol Biol Phys 1985;11:907-14.
176. Lund MB, Kongerud J, Brinch L, Evensen SA, Boe J. Decreased lung function in one year survivors of allogeneic bone marrow transplantation conditioned with high-dose busulphan and cyclophosphamide. Eur Respir J 1995;8:1269-74.
177. Hartsell WF, Czyzewsli EA, Ghalie R, Kaizer H. Pulmonary complications of bone marrow transplantation: a comparison of total body irradiation and cyclophosphamide to busulfan and cyclophosphamide. Int J Radiat Oncol Biol Phys 1995;32:69-73.
178. Collis CH. Lung damage from cytotoxic drugs. Cancer Chemo Pharm 1980;4:17-27.
179. Van Why SK, Friedman AL, Wei LJ, Hong R. Renal insufficiency after bone marrow transplantation in children. Bone Marrow Transplant 1991;7:383-8.
180. Tarbell NJ, Guinan EC, Niemeyer C, Mauch P, Sallan SE, Weinstein HJ. Late onset of renal dysfunction in survivors of bone marrow transplantation. Int J Radiat Oncol Biol Phys 1988;15:99-104.
181. Berns JS, Ford PA. Renal toxicities of antineoplastic drugs and bone marrow transplantation. Semin Nephrol 1997;17:54-66.
182. Kumar M, Kedar A, Neiberger RE. Kidney function in long-term pediatric survivors of acute lymphoblastic leukemia following allogeneic bone marrow transplantation. Pediatr Hematol Oncol 1996;13:375-9.
183. Locasciulli A, Testa M, Valsecchi MG, Vecchi L, Longoni D, Sparano P, et al. Morbidity and mortality due to liver disease in children undergoing allogeneic bone marrow transplantation: a 10 year prospective study. Blood 1997;90:3799-805.
184. Fujii Y, Kaku K, Tanaka M, Kaneko T, Matumoto N, Shinohara K. Hepatitis C virus infection and liver disease after allogeneic bone marrow transplantation. Bone Marrow Transplant 1994;13:523-6.
185. Kolho E, Ruutu P, Ruutu T. Hepatitis C infection in BMT patients. Bone Marrow Transplant 1993;11:119-23.
186. Ljungman P, Johansson N, Aschan J, Glaumann H, Lonnqvist B, Ringden O, et al. Long-term effects of hepatitis C virus infection in allogeneic bone marrow transplant recipients. Blood 1995;86:1614-8.
187. Vento S, Garofano T, Renzini C, Cainelli F, Casali F, Ghironzi G, et al. Fulminant hepatitis associated with hepatitis A virus superinfection in patients with chronic hepatitis C. N Engl J Med 1998;338:286-90.
188. Tichelli A, Gratwohl A, Egger T, Roth J, Prünte A, Nissen C, et al. Cataract formation after bone marrow transplantation. Ann Intern Med 1993;119:1175-80.
189. Calissendorff BM, Bolme P. Cataract development and outcome of surgery in bone marrow transplanted children. Br J Ophthalmol 1993;77:36-8.
190. Dahllöf G, Barr M, Bolme P, Modéer T, Lönnqvist B, Ringdén O, et al. Disturbances in dental development after total body irradiation in bone marrow transplant recipients. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 1988;65:41-4.
191. Dahllöf G, Bågesund M, Ringdén O. Impact of conditioning regimens on salivary function, caries-associated microorganisms and dental caries in children after bone marrow transplantation: a 4-year longitudinal study. Bone Marrow Transplant 1997;20:479-83.
192. Bhatia S, Ramsay NKC, Steinbuch M, Dusenberry KE, Shapiro RS, Weisdorf DJ, et al. Malignant neoplasms following bone marrow transplantation. Blood 1996;87:3633-9.
193. Witherspoon RP, Fisher LD, Schoch G, Martin P, Sullivan KM, Sanders J, et al. Secondary cancers after bone marrow transplantation for leukemia or aplastic anemia. N Engl J Med 1989;321:784-9.
194. Papadopoulos E, Carabasi MH, Castro-Malaspina H, Childs BH, Mackinnon S, Boulad F, et al. T-cell depleted allogeneic bone marrow transplantation as postremission therapy for acute myelogenous leukemia freedom from relapse in the absence of graft-versus-host disease. Blood 1998;91:1083-90.
195. Curtis RE, Rowlings PA, Deeg HJ, Shriner DA, Socié G, Travis LB, et al. Solid cancers after bone marrow transplantation. N Engl J Med 1997;336:897-904.
196. Deeg HJ, Socié G, Schoch G, Henry-Amar M, Witherspoon RP, Devergie A, et al. Malignancies after marrow transplantation for aplastic anemia and Fanconi Anemia: a joint Seattle and Paris analysis of results in 700 patients. Blood 1996;87:386-92.